azacitidine has been researched along with Infections, Pseudomonas in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guijarro-Llorca, J; Toledo-Alberola, F | 1 |
Champlin, R; Davis, M; de Vos, D; Giralt, S; Kantarjian, H; O'Brien, S; van Besien, K | 1 |
1 trial(s) available for azacitidine and Infections, Pseudomonas
Article | Year |
---|---|
Studies of decitabine with allogeneic progenitor cell transplantation.
Topics: Adult; Antimetabolites, Antineoplastic; Azacitidine; Combined Modality Therapy; Decitabine; Drug Administration Schedule; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Middle Aged; Patient Selection; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudomonas Infections; Recurrence; Time Factors; Transplantation, Homologous | 1997 |
1 other study(ies) available for azacitidine and Infections, Pseudomonas
Article | Year |
---|---|
Rapidly growing ulcer in a patient with neurofibromatosis type I.
Topics: Adrenal Gland Neoplasms; Antimetabolites, Antineoplastic; Azacitidine; Fatal Outcome; Humans; Hypothyroidism; Immunocompromised Host; Leg Ulcer; Leukemia, Myelomonocytic, Chronic; Leukemic Infiltration; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Neoplasms, Second Primary; Neurofibromatosis 1; Pheochromocytoma; Pseudomonas Infections; Staphylococcal Infections | 2012 |